Pegvisomant in Acromegaly and Gigantism
Pegvisomant is a GH antagonist used in acromegaly in gigantism. Pegvisomant is a modified GH molecule with pegylation to increase half-life and nine amino acid substitutions to modify GH receptor affinity and dimerization. Pegvisomant leads to an IGF1 decrease. It is administered subcutaneously ever...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2020
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/71104 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Pegvisomant in Acromegaly and Gigantism
- Acromegaly and Gigantism
- G-Protein Coupled Hormone Receptors of the Hypothalamic-Pituitary-Gonadal Axis are Targets of Endocrine Disrupting Chemicals
- The Surgical Management of Acromegaly
- Acromegaly: Overview and Current Management Options
- Colorectal Neoplasm in Acromegaly: Epidemiology and Underlying Mechanisms
- Using a Precision Approach to Optimize the Drug Therapy of Patients with Acromegaly Syndrome